Literature DB >> 18932259

Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome.

Graça M Dores1, Rochelle E Curtis, Jorge R Toro, Susan S Devesa, Joseph F Fraumeni.   

Abstract

BACKGROUND: Sebaceous tumors of the skin occurring in association with an internal malignancy characterize Muir-Torre syndrome (MTS), a variant of hereditary nonpolyposis colon cancer (Lynch syndrome). To the authors' knowledge, only limited information exists regarding incidence patterns of sebaceous carcinoma (SC), and no prior study has quantified risks of associated cancers.
METHODS: The authors calculated cutaneous SC incidence rates (IRs) and IR ratios in 9 US Surveillance, Epidemiology, and End Results program registries (1973-2003). Indirectly standardized incidence ratios and 95% confidence intervals (95% CIs) were calculated for subsequent cancers among 2-month survivors of SC and for subsequent SC after other primary cancers.
RESULTS: Among 664 cases of cutaneous SC, nearly 90% were diagnosed among whites (IR, 0.11 per 100,000 person-years), with significantly lower IR noted among blacks (IR, 0.04). Whereas eyelid SC IRs demonstrated no sex differences and stabilized in recent years, IRs of noneyelid SC predominated in men and rose steadily over time. Survivors of SC had a 43% (95% CI, 15%-76%) increased risk of subsequent cancer, and risk of SC was elevated by 52% (95% CI, 24%-84%) among survivors of other cancers. Whether before or after SC, the significant excesses of other primary cancers were limited to noneyelid SC. Patterns suggestive of genetic predisposition included >20-fold risks for early-onset (diagnosed in patients aged <50 years) SC associated with colon, pancreatic, ovarian, or uterine corpus cancers, whereas late-onset SC (diagnosed in patients aged > or =50 years) predisposed to ureter cancer.
CONCLUSIONS: This population-based study of cutaneous SC revealed an association with a spectrum of early-onset cancers consistent with MTS. Etiologic heterogeneity was suggested by differences between eyelid and noneyelid SC in incidence patterns and associated cancer risks.

Entities:  

Mesh:

Year:  2008        PMID: 18932259      PMCID: PMC2613970          DOI: 10.1002/cncr.23963

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  42 in total

1.  Graphical presentation of trends in rates.

Authors:  S S Devesa; J Donaldson; T Fears
Journal:  Am J Epidemiol       Date:  1995-02-15       Impact factor: 4.897

Review 2.  Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome.

Authors:  P R Cohen; S R Kohn; R Kurzrock
Journal:  Am J Med       Date:  1991-05       Impact factor: 4.965

3.  Search for accumulation of p53 protein and detection of human papillomavirus genomes in sebaceous gland carcinoma of the eyelid.

Authors:  N Hayashi; M Furihata; Y Ohtsuki; H Ueno
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  Sebaceous carcinoma of the eyelid. Errors in clinical and pathologic diagnosis.

Authors:  J T Wolfe; R P Yeatts; M R Wick; R J Campbell; R R Waller
Journal:  Am J Surg Pathol       Date:  1984-08       Impact factor: 6.394

Review 5.  Muir-Torre syndrome.

Authors:  P R Cohen; S R Kohn; D A Davis; R Kurzrock
Journal:  Dermatol Clin       Date:  1995-01       Impact factor: 3.478

6.  Sebaceous gland carcinoma. Review of 40 cases.

Authors:  M T Doxanas; W R Green
Journal:  Arch Ophthalmol       Date:  1984-02

7.  Unusual eyelid tumors with sebaceous differentiation in the Muir-Torre syndrome. Rapid clinical regrowth and frank squamous transformation after biopsy.

Authors:  F A Jakobiec; L E Zimmerman; F La Piana; A Hornblass; R A Breffeilh; J K Lackey
Journal:  Ophthalmology       Date:  1988-11       Impact factor: 12.079

Review 8.  Sebaceous carcinoma.

Authors:  B R Nelson; K R Hamlet; M Gillard; D Railan; T M Johnson
Journal:  J Am Acad Dermatol       Date:  1995-07       Impact factor: 11.527

9.  Microsatellite instability in Muir-Torre syndrome.

Authors:  R Honchel; K C Halling; D J Schaid; M Pittelkow; S N Thibodeau
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

Review 10.  Sebaceous carcinoma of the head and neck. Case report and literature review.

Authors:  J W Bailet; M C Zimmerman; D P Arnstein; J S Wollman; R A Mickel
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1992-11
View more
  19 in total

1.  Primary cutaneous adenoid cystic carcinoma in the United States: incidence, survival, and associated cancers, 1976 to 2005.

Authors:  Graça M Dores; Mark M Huycke; Susan S Devesa; Carlos A Garcia
Journal:  J Am Acad Dermatol       Date:  2010-05-05       Impact factor: 11.527

Review 2.  Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications.

Authors:  Sara C Shalin; Stephen Lyle; Eduardo Calonje; Alexander J F Lazar
Journal:  Histopathology       Date:  2010-01       Impact factor: 5.087

3.  The liver: another organ involved in Muir Torre syndrome?

Authors:  F Morando; M Alaibac; A Romano; M Cavallin; S Piano; M Pizzi; C Mescoli; P Pilati; A Gatta; P Angeli
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

4.  A Case of Rapidly Growing Extraocular Sebaceous Carcinoma.

Authors:  Joon Ho Lee; Hea-Kyeong Shin; Tae Jung Jang
Journal:  Arch Craniofac Surg       Date:  2014-04-10

Review 5.  Sebaceous Carcinoma: A Review of the Scientific Literature.

Authors:  Thomas Knackstedt; Faramarz H Samie
Journal:  Curr Treat Options Oncol       Date:  2017-08

6.  Incidence and Clinical Features of Rare Cutaneous Malignancies in Olmsted County, Minnesota, 2000 to 2010.

Authors:  Stanislav N Tolkachjov; Adam R Schmitt; John G Muzic; Amy L Weaver; Christian L Baum
Journal:  Dermatol Surg       Date:  2017-01       Impact factor: 3.398

7.  Elevated risk of prostate cancer among men with Lynch syndrome.

Authors:  Victoria M Raymond; Bhramar Mukherjee; Fei Wang; Shu-Chen Huang; Elena M Stoffel; Fay Kastrinos; Sapna Syngal; Kathleen A Cooney; Stephen B Gruber
Journal:  J Clin Oncol       Date:  2013-03-25       Impact factor: 44.544

Review 8.  Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation.

Authors:  Iyer Vishwas Neelakantan; Silvana Di Palma; C E T Smith; A McCoombe
Journal:  Head Neck Pathol       Date:  2015-11-17

9.  Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States.

Authors:  Emilie Lanoy; Graça M Dores; Margaret M Madeleine; Jorge R Toro; Joseph F Fraumeni; Eric A Engels
Journal:  AIDS       Date:  2009-01-28       Impact factor: 4.177

Review 10.  Muir-Torre Syndrome Associated Periocular Sebaceous Neoplasms: Screening Patterns in the Literature and in Clinical Practice.

Authors:  Maya Eiger-Moscovich; Ralph C Eagle; Carol L Shields; Hilary Racher; Sara E Lally; Rona Z Silkiss; Jerry A Shields; Tatyana Milman
Journal:  Ocul Oncol Pathol       Date:  2020-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.